• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度北部一家三级护理中心临床及环境分离曲霉菌株的抗真菌药敏谱

Antifungal Susceptibility Profile of Clinical and Environmental Isolates of Aspergillus Species From a Tertiary Care Center in North India.

作者信息

Kaur Manharpreet, Singla Nidhi, Aggarwal Deepak, Kundu Reetu, Gulati Neelam, Kumar Mani Bhushan, Gombar Satinder, Chander Jagdish

机构信息

Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, Chandigarh, IND.

Microbiology, Government Medical College, Chandigarh, Chandigarh, IND.

出版信息

Cureus. 2024 Feb 20;16(2):e54586. doi: 10.7759/cureus.54586. eCollection 2024 Feb.

DOI:10.7759/cureus.54586
PMID:38524068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10958134/
Abstract

INTRODUCTION

species are ubiquitously found in the environment worldwide and are important causative agents for infection. Drug resistance among species is emerging, hence the present study was undertaken to look for antifungal susceptibility profiles of clinical and environmental isolates of species.

MATERIALS AND METHODS

During the period from January 2018 to June 2019, a total of 102 isolates (40 clinical, 40 hospital, and 22 community environment) were tested for antifungal susceptibility testing for determination of minimum inhibitory concentration (MIC)/minimum effective concentration (MEC) as per Clinical and Laboratory Standards Institute (CLSI) M38-A3 method for itraconazole, voriconazole, amphotericin B, and caspofungin.

RESULTS

Out of these 102 isolates, was the most common species present. species were found to have low MIC values to azoles such as itraconazole and voriconazole except for one clinical isolate, which showed a MIC value of 2 μg/ml to voriconazole. Two isolates were non-wild-type for amphotericin B, but all isolates were wild-type for caspofungin.

CONCLUSION

Antifungal susceptibility testing among clinical isolates and environmental surveillance studies in view of emerging drug resistance should be undertaken at a larger scale.

摘要

引言

[具体物种名称]在全球环境中普遍存在,是重要的感染病原体。[具体物种名称]的耐药性正在出现,因此开展本研究以探寻该物种临床和环境分离株的抗真菌药敏谱。

材料与方法

在2018年1月至2019年6月期间,共对102株[具体物种名称]分离株(40株临床分离株、40株医院分离株和22株社区环境分离株)进行抗真菌药敏试验,按照临床和实验室标准协会(CLSI)M38 - A3方法测定伊曲康唑、伏立康唑、两性霉素B和卡泊芬净的最低抑菌浓度(MIC)/最低有效浓度(MEC)。

结果

在这102株[具体物种名称]分离株中,[具体物种名称]是最常见的物种。除1株临床分离株对伏立康唑的MIC值为2μg/ml外,[具体物种名称]对伊曲康唑和伏立康唑等唑类药物的MIC值较低。有2株分离株对两性霉素B为非野生型,但所有分离株对卡泊芬净均为野生型。

结论

鉴于耐药性的出现,应更大规模地开展临床[具体物种名称]分离株的抗真菌药敏试验和环境监测研究。

相似文献

1
Antifungal Susceptibility Profile of Clinical and Environmental Isolates of Aspergillus Species From a Tertiary Care Center in North India.印度北部一家三级护理中心临床及环境分离曲霉菌株的抗真菌药敏谱
Cureus. 2024 Feb 20;16(2):e54586. doi: 10.7759/cureus.54586. eCollection 2024 Feb.
2
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.CLSI 和 EUCAST 肉汤微量稀释法检测新型广谱抗真菌药物 E1210 对曲霉菌属的体外活性。
Antimicrob Agents Chemother. 2011 Nov;55(11):5155-8. doi: 10.1128/AAC.00570-11. Epub 2011 Aug 15.
3
Multicenter Study of Susceptibility of Aspergillus Species Isolated from Iranian University Hospitals to Seven Antifungal Agents.伊朗大学医院分离的曲霉菌属对七种抗真菌药物的敏感性的多中心研究。
Microbiol Spectr. 2022 Jun 29;10(3):e0253921. doi: 10.1128/spectrum.02539-21. Epub 2022 May 17.
4
Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.评估印度北部一家三级护理中心真菌性角膜炎的抗真菌药敏性和临床特征。
Indian J Ophthalmol. 2022 Dec;70(12):4270-4283. doi: 10.4103/ijo.IJO_855_22.
5
Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.比较 Sensititre YeastOne 和 CLSI M38-A2 微量稀释法测定两性霉素 B、伊曲康唑、伏立康唑和泊沙康唑对曲霉属的活性。
J Clin Microbiol. 2018 Sep 25;56(10). doi: 10.1128/JCM.00780-18. Print 2018 Oct.
6
Species distribution and antifungal susceptibility of clinical Aspergillus isolates: A multicentre study in Taiwan, 2016-2020.2016-2020 年台湾地区临床曲霉属分离株的种分布及抗真菌药敏性:一项多中心研究。
Mycoses. 2023 Aug;66(8):711-722. doi: 10.1111/myc.13593. Epub 2023 Apr 26.
7
Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.从眼部真菌病患者分离出的非烟曲霉属真菌的时间-杀菌动力学及体外抗真菌药敏性
Mycopathologia. 2016 Apr;181(3-4):225-33. doi: 10.1007/s11046-015-9969-z. Epub 2015 Nov 26.
8
In vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in Brazil.巴西烟曲霉和黄曲霉临床及环境分离株的体外抗真菌药敏性
Braz J Infect Dis. 2018 Jan-Feb;22(1):30-36. doi: 10.1016/j.bjid.2017.10.005. Epub 2017 Nov 22.
9
A 20-Year Antifungal Susceptibility Surveillance (From 1999 to 2019) for spp. and Proposed Epidemiological Cutoff Values for and : A Study in a Tertiary Hospital in China.某菌属20年抗真菌药敏监测(1999年至2019年)及该菌属和另一菌属的拟议流行病学截断值:中国一家三级医院的研究
Front Microbiol. 2021 Jul 22;12:680884. doi: 10.3389/fmicb.2021.680884. eCollection 2021.
10
Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018-2021) and application of single-site epidemiological cutoff values to evaluate amphotericin B activity.来自哨兵抗真菌监测项目(2018 - 2021年)中引起侵袭性霉菌感染的分离株对两性霉素B、伊曲康唑、泊沙康唑、伏立康唑和卡泊芬净的药敏模式,以及应用单部位流行病学截断值评估两性霉素B的活性。
Mycoses. 2023 Oct;66(10):854-868. doi: 10.1111/myc.13620. Epub 2023 Jul 11.

引用本文的文献

1
Prevalence of fungi and their antifungal and disinfectant resistance in hospital environments: insights into combating nosocomial mycoses.医院环境中真菌的流行情况及其抗真菌和消毒剂耐药性:对抗医院内真菌病的见解
Antimicrob Resist Infect Control. 2025 Apr 23;14(1):37. doi: 10.1186/s13756-025-01558-x.
2
Comprehensive Review of Environmental Surveillance for Azole-Resistant : A Practical Roadmap for Hospital Clinicians and Infection Control Teams.唑类耐药环境监测综合综述:医院临床医生和感染控制团队实用路线图
J Fungi (Basel). 2025 Jan 25;11(2):96. doi: 10.3390/jof11020096.

本文引用的文献

1
Trends in the Prevalence of Amphotericin B-Resistance (AmBR) among Clinical Isolates of Aspergillus Species.曲霉属临床分离株中两性霉素B耐药性(AmBR)的流行趋势
J Mycol Med. 2022 Nov;32(4):101310. doi: 10.1016/j.mycmed.2022.101310. Epub 2022 Jul 14.
2
Echinocandin Resistance in Has Broad Implications for Membrane Lipid Perturbations That Influence Drug-Target Interactions.棘白菌素耐药性对影响药物-靶点相互作用的膜脂质扰动具有广泛影响。
Microbiol Insights. 2019 Dec 31;12:1178636119897034. doi: 10.1177/1178636119897034. eCollection 2019.
3
Trends in Agricultural Triazole Fungicide Use in the United States, 1992-2016 and Possible Implications for Antifungal-Resistant Fungi in Human Disease.美国 1992-2016 年农用三唑类杀真菌剂使用趋势及其对人类疾病中抗真菌耐药真菌的可能影响。
Environ Health Perspect. 2021 May;129(5):55001. doi: 10.1289/EHP7484. Epub 2021 May 5.
4
Updated EUCAST Clinical Breakpoints against , Implications for the Clinical Microbiology Laboratory.针对……的更新后的欧盟CAST临床断点,对临床微生物实验室的影响。 (你提供的原文“against”后面缺少具体内容,以上翻译是根据现有内容尽量完善后的结果)
J Fungi (Basel). 2020 Dec 6;6(4):343. doi: 10.3390/jof6040343.
5
Invasive Aspergillosis by : Epidemiology, Diagnosis, Antifungal Resistance, and Management.《侵袭性曲霉病:流行病学、诊断、抗真菌耐药性及治疗》
J Fungi (Basel). 2019 Jul 1;5(3):55. doi: 10.3390/jof5030055.
6
Echinocandins for the Treatment of Invasive Aspergillosis: from Laboratory to Bedside.棘白菌素类药物治疗侵袭性曲霉病:从实验室到临床。
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.00399-19. Print 2019 Aug.
7
Antifungal Resistance in Clinical Isolates of spp.: When Local Epidemiology Breaks the Norm.某菌临床分离株中的抗真菌耐药性:当局部流行病学打破常规时。 (注:原文中“ spp.”指代不明,这里只能根据语境大概如此翻译。)
J Fungi (Basel). 2019 May 21;5(2):41. doi: 10.3390/jof5020041.
8
How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates.方法:EUCAST 关于使用含唑类药物的四孔琼脂平板检测烟曲霉分离株中唑类耐药性的筛选程序 E.Def 10.1 的建议。
Clin Microbiol Infect. 2019 Jun;25(6):681-687. doi: 10.1016/j.cmi.2018.09.008. Epub 2018 Sep 28.
9
Magnitude of Voriconazole Resistance in Clinical and Environmental Isolates of Aspergillus flavus and Investigation into the Role of Multidrug Efflux Pumps.黄曲霉临床和环境分离株中伏立康唑耐药程度及多药外排泵作用的研究。
Antimicrob Agents Chemother. 2018 Oct 24;62(11). doi: 10.1128/AAC.01022-18. Print 2018 Nov.
10
In vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in Brazil.巴西烟曲霉和黄曲霉临床及环境分离株的体外抗真菌药敏性
Braz J Infect Dis. 2018 Jan-Feb;22(1):30-36. doi: 10.1016/j.bjid.2017.10.005. Epub 2017 Nov 22.